Xiaoli Lan
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Oncology top 2%
- Peptidase Inhibition and Analysis
Papers in
- Oncology 79
- Peptidase Inhibition and Analysis 40
-
- Radiopharmaceutical Chemistry and Applications 37
- Medical Imaging Techniques and Applications 19
- Monoclonal and Polyclonal Antibodies Research 15
- Radiomics and Machine Learning in Medical Imaging 14
- Co-authors
- Chunxia Qin (57 shared papers)Weibo Cai (29 shared papers)Yongxue Zhang (65 shared papers)Yongkang Gai (71 shared papers)Dawei Jiang (52 shared papers)Qingyao Liu (32 shared papers)Mengting Li (23 shared papers)Dalong Ni (7 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (39 papers)Molecular Pharmaceutics (18 papers)Journal of Nuclear Medicine (11 papers)Journal of Nanobiotechnology (9 papers)Nuclear Medicine and Biology (9 papers)
- Partner nations
- ChinaUnited StatesChile
In The Last Decade
Xiaoli Lan
253 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 143
- Radiology, Nuclear Medicine and Imaging 1.1k
- Oncology 1.2k
- Biomaterials 545
- Biomedical Engineering 1.6k
- Cancer Research 469
Countries citing papers authored by Xiaoli Lan
This map shows the geographic impact of Xiaoli Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Lan more than expected).
Fields of papers citing papers by Xiaoli Lan
This network shows the impact of papers produced by Xiaoli Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Lan. The network helps show where Xiaoli Lan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 266 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 329 | |
| 2 | 2019 | 211 | |
| 3 | 2020 | 196 | |
| 4 | 2021 | 118 | |
| 5 | 2020 | 114 | |
| 6 | 2019 | 104 | |
| 7 | 2013 | 104 | |
| 8 | 2019 | 102 | |
| 9 | 2017 | 94 | |
| 10 | 2022 | 90 | |
| 11 | 2014 | 85 | |
| 12 | 2008 | 81 | |
| 13 | 2015 | 79 | |
| 14 | 2020 | 77 | |
| 15 | 2021 | 76 | |
| 16 | 2013 | 75 | |
| 17 | 2017 | 74 | |
| 18 | 2018 | 66 | |
| 19 | 2021 | 65 | |
| 20 | 2019 | 64 |
About Xiaoli Lan
Xiaoli Lan is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Biomedical Engineering and Pulmonary and Respiratory Medicine, having authored 266 papers that have together received 5.3k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (40 papers), Radiopharmaceutical Chemistry and Applications (37 papers), Nanoplatforms for cancer theranostics (33 papers), Medical Imaging Techniques and Applications (19 papers), Cardiac Structural Anomalies and Repair (17 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Radiomics and Machine Learning in Medical Imaging (14 papers) and Cancer, Hypoxia, and Metabolism (13 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.1k citations), Oncology (1.2k citations), Biomaterials (545 citations), Biomedical Engineering (1.6k citations) and Cancer Research (469 citations). Xiaoli Lan has collaborated with scholars based in China, United States and Chile. Frequent co-authors include Chunxia Qin, Weibo Cai, Yongxue Zhang, Yongkang Gai, Dawei Jiang, Qingyao Liu, Mengting Li, Dalong Ni, Fuqiang Shao and Fan Hu. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Molecular Pharmaceutics, Journal of Nuclear Medicine, Journal of Nanobiotechnology and Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.